Collaborative for Healthcare Action to Reduce MedTech Emissions (CHARME)



CHARME logo

About CHARME

CHARME is an initiative convening health systems, medical device and equipment suppliers, distributors, GPOs, and other key industry stakeholders to define, implement, and champion best practices to reduce emissions from the MedTech supply chain. CHARME members will work collaboratively to implement actions along a 24-month decarbonization roadmap defined in the white paper Catalyzing Collective Action to Decarbonize Healthcare Roadmap for Health Systems and MedTech Suppliers,  published in May 2023 with input from over 30 organizations.

Sign Up for the CHARME Newsletter


CHARME is being convened to address a gap in current industry initiatives related to reducing supply chain greenhouse gas emissions for medical devices and supplies, which makes up 7% of the health sector’s US footprint. Multi-stakeholder collaboration is needed to decarbonize at the pace and scale required, and working together will provide efficiencies and innovation no single company can achieve alone.

Learn More about CHARME

How CHARME Works

CHARME will be an action-oriented, 24-month initiative laser-focused on enabling collaborative efforts within the health value chain to achieve rapid progress toward industry and individual members’ decarbonization goals. CHARME members actively participate in at least one of the initiative’s workstreams to amplify the individual progress each member is making towards emissions reduction goals. 

CHARME officially launched on April 9th 2024 and more participants are joining every day! If you weren't able to attend the Launch Webinar event, here's the recording where you can hear from program conveners and industry leaders about why this collaborative is so important:

Watch the CHARME Launch Recording

CHARME’s Focus for Impact

CHARME participants have selected four workstreams to mobilize collaboration for near-term efforts to decarbonize the MedTech value chain:

CHARME workstreams

Embedded carbon in MedTech products contributes substantially to both health system and supplier Scope 3 emissions. However, changing products can be particularly challenging because design and manufacturing changes may require significant upfront investment, longer timelines, and regulatory considerations. Collaboration between health systems and MedTech suppliers creates a significant opportunity to focus on specific subsets or categories of products and identify best practices to decarbonize across the product lifecycle.

The workstream participants have defined three focus areas:

  • Bio-based plastics: Transition single-use, petroleum-based products to a bio-based alternative.
  • Regional material recovery facility (MRF): Produce a roadmap for launching a collective MRF to aggregate healthcare plastics to improve recycling opportunities.
  • European & Asian product assessment: Evaluate sustainable products available in global markets and support market expansion to the United States. 

Product utilization plays an important role in the emissions generated over the course of a product’s lifecycle. The Product Durability workstream is evaluating opportunities to replace single-use devices with durable options while maintaining patient safety in different clinical environments.

The workstream participants have defined three product focus areas:

  • Blood pressure cuffs
  • Pulse oximeters
  • Isolation gowns 

Clinicians and other clinical staff are not only key decision makers on the types of products being procured, but also determine where, when, how, and how much of products are being used. This workstream is looking at ways to accelerate adoption of reprocessed single-use devices (SUDs).

The workstream participants have defined four focus areas:

  • Product piloting: Pilot new reprocessed products at health systems to increase breadth of adoption.
  • Improving contract language: Develop language for health systems to use that supports adoption of reprocessed product usage without impacting total cost.
  • Education and awareness: Educate clinicians, sustainability, and procurement staff on availability, safety, and efficacy of reprocessed SUDs and best practices.
  • Supporting end-of-life processes: Improve end-of-life outcomes after use of reprocessed devices.

Transitioning to renewable energy is critical to decarbonization. In this workstream, health systems and MedTech suppliers are aggregating their energy demand to buy renewable electricity through a Virtual Power Purchase Agreement (VPPA). VPPAs are financial agreements where a solar developer designs, permits, and installs a solar energy system, then sells the power generated to a customer at a fixed rate typically lower than the local utility’s retail rate. Aggregate Power Purchase Agreements allow organizations to procure renewable electricity at a lower price, enable smaller companies to participate, and bring new renewable capacity onto the grid.

CHARME Participant Requirements

CHARME is an action-oriented, 24-month initiative laser focused on enabling meaningful efforts with the health value chain. The shared work and outputs of CHARME will build on an amplify participating organizations’ progress towards emissions reduction goals. To ensure that CHARME enables these outcomes, participants are asked to meet the following requirements: 

  1. Have a public greenhouse gas emissions reduction goal in place.
  2. Appoint a sustainability representative, a procurement representative, a clinical or product representative to participate in CHARME activities as needed, and a C-suite sponsor.
  3. Participate in at least one CHARME workstream.
  4. Attend at least 75% of CHARME meetings.


The estimated organizational time commitment for a CHARME participant is 4-6 hours per month. 


Current CHARME Participants 

Co-Chairs 
Kaiser Permanente  Vizient 

Key Supporters

BD (Becton, Dickinson and Company)

Cencora

GE HealthCare

Henry Schein

Johnson & Johnson

McKesson

Stryker 

Health Systems and Suppliers *

Advocate Health

Allina Health

Ambu

Boston Medical Center

Boston Scientific

Cardinal Health

Hackensack Meridian Health

Innovative Health

Legacy Health

Mass General Brigham

Mayo Clinic

Medtronic

Northwell Health

Philips

Providence 

Roche

SSM Health

Stanford Health Care

NGO Partners

AHRMM 

Health Care Without Harm

Healthcare Plastics Recycling Council (HPRC)

Institute for Healthcare Improvement (IHI)

National Academy of Medicine

The Society for Healthcare Epidemiology of America (SHEA)

* Additional participants to be listed soon


Thanks to the organizations that have provided seed funding for this project.

Kaiser Permanente Vizient Logo


CHARME is advised by:

Accenture logo

The SPLC is proud to serve as CHARME's host organization, bringing key sustainable procurement expertise with a proven track record of building coalitions and supporting organizations as they design and execute meaningful sustainable procurement strategies. 

Learn More about CHARME